Evidence that interleukin-1β and tumor necrosis factor inhibit gastric fundus motility via the 5-lipoxygenase pathway
- 11 February 1994
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 252 (3) , 253-260
- https://doi.org/10.1016/0014-2999(94)90170-8
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Interleukin-1α and tumour necrosis factor inhibit rat gastric fundus motility in vitroEuropean Journal of Pharmacology, 1993
- Interleukin-1β and Interleukin-6 Specifically Increase the Release of Prostaglandin E2 from Rat Hypothalamic Explants in vitroNeuroendocrinology, 1992
- The molecular action of tumor necrosis factor‐αEuropean Journal of Biochemistry, 1991
- A novel anti‐inflammatory peptide from human lipocortin 5British Journal of Pharmacology, 1991
- Interleukin-1 and interleukin-1 antagonismBlood, 1991
- Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells.Journal of Clinical Investigation, 1991
- Interleukin 1 inhibits contraction of vascular smooth muscle.Journal of Clinical Investigation, 1989
- Lipocortin and the mechanism of action of the glucocorticoidsBritish Journal of Pharmacology, 1988
- Cachectin: More Than a Tumor Necrosis FactorNew England Journal of Medicine, 1987
- The reactivity of rat isolated gastrointestinal tissues to leukotrienesEuropean Journal of Pharmacology, 1982